416 related articles for article (PubMed ID: 34476752)
1. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M
Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752
[TBL] [Abstract][Full Text] [Related]
2. [Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].
Jasso-Rangel M; Vargas-Martínez KO; Camacho-Frausto LY; Galindo-Félix A; Román-Esquivel JV; Lara-Ramírez EE
Rev Med Inst Mex Seguro Soc; 2022 Feb; 60(1):91-95. PubMed ID: 35274917
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
Olbert E; Alhani N; Struhal W
Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
Chakraborty U; Hati A; Chandra A
Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
Front Immunol; 2022; 13():894872. PubMed ID: 35924236
[TBL] [Abstract][Full Text] [Related]
6. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
Puma A; Benoit J; Sacconi S; Uncini A
BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome.
Lascano AM; Epiney JB; Coen M; Serratrice J; Bernard-Valnet R; Lalive PH; Kuntzer T; Hübers A
Eur J Neurol; 2020 Sep; 27(9):1751-1753. PubMed ID: 32478936
[TBL] [Abstract][Full Text] [Related]
9. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes.
Tatsumoto M; Misawa S; Kokubun N; Sekiguchi Y; Hirata K; Kuwabara S; Yuki N
Muscle Nerve; 2015 Jun; 51(6):811-4. PubMed ID: 25287079
[TBL] [Abstract][Full Text] [Related]
10. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
11. Miller-Fisher syndrome after SARS-CoV-2 infection.
Reyes-Bueno JA; García-Trujillo L; Urbaneja P; Ciano-Petersen NL; Postigo-Pozo MJ; Martínez-Tomás C; Serrano-Castro PJ
Eur J Neurol; 2020 Sep; 27(9):1759-1761. PubMed ID: 32503084
[TBL] [Abstract][Full Text] [Related]
12. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
[TBL] [Abstract][Full Text] [Related]
13. Miller-Fisher syndrome associated with SARS-CoV-2: a case report.
Faulkner L; Scott S; Flint N
Microbes Infect; 2022; 24(5):104954. PubMed ID: 35240290
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report.
Mohammadi SM; Abdi R; Karimi Z; Mortazavi F
J Med Case Rep; 2022 Feb; 16(1):63. PubMed ID: 35135595
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
16. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
[TBL] [Abstract][Full Text] [Related]
17. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review.
Liang H; Cao Y; Zhong W; Ma Z; Liu J; Chen H
Hum Vaccin Immunother; 2022 Nov; 18(6):2125753. PubMed ID: 36315834
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Four cases of SARS-CoV-2-associated Guillain-Barré Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China.
Guan Y; Yu C; Fei Y; Wang Q; Wang P; Zuo W; Wu H; Qi X; Shi Q
Front Immunol; 2023; 14():1258579. PubMed ID: 37701436
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
Papri N; Hayat S; Mohammed A; Afsar MNA; Hasan I; Rahman A; Jahan I; Islam Z
J Neuroimmunol; 2021 Jul; 356():577590. PubMed ID: 33957540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
